Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score below 5 percent. (HealthDay News) — In a clinical guideline issued by ...

The 2026 American dyslipidemia guideline now endorses the PREVENT equations to guide lipid-lowering therapy in primary prevention in adults. Lipid-lowering therapy can be considered with a 10-year ...

New cholesterol guidelines advise against OTC fish oil for lowering LDL cholesterol and recommend earlier screening, stricter LDL targets and timely statin use in high-risk adults.

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

The American Heart Association and the American College of Cardiology, along with several partner medical societies, released ...

For the first time since 2018, a clinical guideline from the American College of Cardiology and the American Heart Association for screening and managing blood cholesterol levels has been updated and ...

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high ...

(HealthDay News) — European and American guidelines lead to different recommendations for statin therapy, according to a study published online in JACC: Cardiovascular Imaging. Amir A. Mahabadi, MD, ...

Doctors have to make tough choices about prescribing medications, weighing the potential risks and benefits. They typically use official recommendations from governing bodies and relevant medical ...

Are you among the 73 million Americans with cholesterol levels that current guidelines suggest should be lowered by taking a statin for the sake of your cardiovascular well-being? Have you and your ...

The trial findings complement the updated US dyslipidemia guidelines that promote early and intensive LDL lowering.

The panel favored statins for patients with a 10-year ASCVD risk score below 5%, but recommended patient-clinician risk discussions that accounted for additional HIV-related risk factors that could ...